Romidepsin

Category: Cancer



Romidepsin Overview

Romidepsin, also known as Istodax, is an anticancer agent used in cutaneous T-cell lymphoma (CTCL) and other peripheral T-cell lymphomas (PTCLs). Romidepsin is a natural product obtained from the bacterium Chromobacterium violaceum, and works by blocking enzymes known as histone deacetylases, thus inducing apoptosis.[1] It is sometimes referred to as depsipeptide, after the class of molecules to which it belongs. Romidepsin is branded and owned by Gloucester Pharmaceuticals, ...

Read more Romidepsin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Romidepsin

Recent Romidepsin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Romidepsin
  • Powder: 10mg/vial
  • Vial: 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Romidepsin: (2 results)

Sorted by National Drug Code
  • 0069-0983 Romidepsin Kit by Pfizer Laboratories Div Pfizer Inc
  • 0703-3125 Romidepsin Kit by Teva Parenteral Medicines, Inc.

Other drugs which contain Romidepsin or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA